                         SEQUENCE LISTING

<110>  Oregon Health & Science University
       The United States Government as Represented by the 
       Department of Veterans Affairs
       Huan, Jianya
       Vandenbark, Arthur A
 
<120>  RECOMBINANT T CELL LIGANDS AND ANTIBODIES THAT BIND B CELLS FOR 
       THE TREATMENT OF AUTOIMMUNE DISEASES

<130>  899-86402-02

<150>  US 61/437,316
<151>  2011-01-28

<160>  45    

<170>  PatentIn version 3.5

<210>  1
<211>  551
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  RTL362 - human HLA-DR4 derived beta1/alpha 1 molecule


<220>
<221>  CDS
<222>  (3)..(542)

<400>  1
cc atg ggg gac acc cga cca cgc ttc ctg gag cag gtt aaa cat gag          47
   Met Gly Asp Thr Arg Pro Arg Phe Leu Glu Gln Val Lys His Glu            
   1               5                   10                  15             

tgt cat ttc ttc aat ggg acg gag cgg gtg cgg ttc ctg gac aga tac         95
Cys His Phe Phe Asn Gly Thr Glu Arg Val Arg Phe Leu Asp Arg Tyr           
                20                  25                  30                

ttc tat cac caa gag gag tac gtg cgc ttc gac agc gac gtg ggg gag        143
Phe Tyr His Gln Glu Glu Tyr Val Arg Phe Asp Ser Asp Val Gly Glu           
            35                  40                  45                    

ttc cgg gcg gtg acg gag ctg ggg cgg cct gac gct gag tac tgg aac        191
Phe Arg Ala Val Thr Glu Leu Gly Arg Pro Asp Ala Glu Tyr Trp Asn           
        50                  55                  60                        

agc cag aag gac ctc ctg gag cag aag cgg gcc gcg gtg gac acc tac        239
Ser Gln Lys Asp Leu Leu Glu Gln Lys Arg Ala Ala Val Asp Thr Tyr           
    65                  70                  75                            

tgc aga cac aac tac ggg gtt ggt gag agc ttc aca gtg cag cgg cga        287
Cys Arg His Asn Tyr Gly Val Gly Glu Ser Phe Thr Val Gln Arg Arg           
80                  85                  90                  95            

gtc atc aaa gaa gaa cat gtg atc atc cag gcc gag ttc tat ctg aat        335
Val Ile Lys Glu Glu His Val Ile Ile Gln Ala Glu Phe Tyr Leu Asn           
                100                 105                 110               

cct gac caa tca ggc gag ttt atg ttt gac ttt gat ggt gat gag att        383
Pro Asp Gln Ser Gly Glu Phe Met Phe Asp Phe Asp Gly Asp Glu Ile           
            115                 120                 125                   

ttc cat gtg gat atg gca aag aag gag acg gtc tgg cgg ctt gaa gaa        431
Phe His Val Asp Met Ala Lys Lys Glu Thr Val Trp Arg Leu Glu Glu           
        130                 135                 140                       

ttt gga cga ttt gcc agc ttt gag gct caa ggt gca ttg gcc aac ata        479
Phe Gly Arg Phe Ala Ser Phe Glu Ala Gln Gly Ala Leu Ala Asn Ile           
    145                 150                 155                           

gct gtg gac aaa gcc aac ctg gaa atc atg aca aag cgc tcc aac tat        527
Ala Val Asp Lys Ala Asn Leu Glu Ile Met Thr Lys Arg Ser Asn Tyr           
160                 165                 170                 175           

act ccg atc acc aat taactcgag                                          551
Thr Pro Ile Thr Asn                                                       
                180                                                       


<210>  2
<211>  180
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  2

Met Gly Asp Thr Arg Pro Arg Phe Leu Glu Gln Val Lys His Glu Cys 
1               5                   10                  15      


His Phe Phe Asn Gly Thr Glu Arg Val Arg Phe Leu Asp Arg Tyr Phe 
            20                  25                  30          


Tyr His Gln Glu Glu Tyr Val Arg Phe Asp Ser Asp Val Gly Glu Phe 
        35                  40                  45              


Arg Ala Val Thr Glu Leu Gly Arg Pro Asp Ala Glu Tyr Trp Asn Ser 
    50                  55                  60                  


Gln Lys Asp Leu Leu Glu Gln Lys Arg Ala Ala Val Asp Thr Tyr Cys 
65                  70                  75                  80  


Arg His Asn Tyr Gly Val Gly Glu Ser Phe Thr Val Gln Arg Arg Val 
                85                  90                  95      


Ile Lys Glu Glu His Val Ile Ile Gln Ala Glu Phe Tyr Leu Asn Pro 
            100                 105                 110         


Asp Gln Ser Gly Glu Phe Met Phe Asp Phe Asp Gly Asp Glu Ile Phe 
        115                 120                 125             


His Val Asp Met Ala Lys Lys Glu Thr Val Trp Arg Leu Glu Glu Phe 
    130                 135                 140                 


Gly Arg Phe Ala Ser Phe Glu Ala Gln Gly Ala Leu Ala Asn Ile Ala 
145                 150                 155                 160 


Val Asp Lys Ala Asn Leu Glu Ile Met Thr Lys Arg Ser Asn Tyr Thr 
                165                 170                 175     


Pro Ile Thr Asn 
            180 


<210>  3
<211>  68
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  RTL363 Peptide/linker insert encoding human collagen II 261-273 
       peptide


<220>
<221>  CDS
<222>  (3)..(68)

<400>  3
cc atg gct ggt ttc aaa ggt gaa cag ggt ccg aaa ggt gaa ccg ggt          47
   Met Ala Gly Phe Lys Gly Glu Gln Gly Pro Lys Gly Glu Pro Gly            
   1               5                   10                  15             

tct ggt tct ggt tct ggt tct                                             68
Ser Gly Ser Gly Ser Gly Ser                                               
                20                                                        


<210>  4
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  4

Met Ala Gly Phe Lys Gly Glu Gln Gly Pro Lys Gly Glu Pro Gly Ser 
1               5                   10                  15      


Gly Ser Gly Ser Gly Ser 
            20          


<210>  5
<211>  74
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  RTL363GI peptide/linker insert encoding human collagen II 261-273
       peptide


<220>
<221>  CDS
<222>  (3)..(74)

<400>  5
cc atg ggt atc gct ggt ttc aaa ggt gaa cag ggt ccg aaa ggt gaa          47
   Met Gly Ile Ala Gly Phe Lys Gly Glu Gln Gly Pro Lys Gly Glu            
   1               5                   10                  15             

ccg ggt tct ggt tct ggt tct ggt tct                                     74
Pro Gly Ser Gly Ser Gly Ser Gly Ser                                       
                20                                                        


<210>  6
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  6

Met Gly Ile Ala Gly Phe Lys Gly Glu Gln Gly Pro Lys Gly Glu Pro 
1               5                   10                  15      


Gly Ser Gly Ser Gly Ser Gly Ser 
            20                  


<210>  7
<211>  572
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  RTL2000 - mouse I-Aq derived beta1/alpha1 molecule


<220>
<221>  CDS
<222>  (3)..(566)

<400>  7
cc atg ggc gga aac tcc gaa agg cat ttc gtg gcc cag ttg aag ggc          47
   Met Gly Gly Asn Ser Glu Arg His Phe Val Ala Gln Leu Lys Gly            
   1               5                   10                  15             

gag tgc tac ttc acc aac ggg acg cag cgc ata cga tct gtg aac aga         95
Glu Cys Tyr Phe Thr Asn Gly Thr Gln Arg Ile Arg Ser Val Asn Arg           
                20                  25                  30                

tac atc tac aac cgg gag gag tgg gtg cgc ttc gac agc gac gtg ggc        143
Tyr Ile Tyr Asn Arg Glu Glu Trp Val Arg Phe Asp Ser Asp Val Gly           
            35                  40                  45                    

gag tac cgc gcg gtg acc gag ctg ggg cgg cca gac gcc gag tac tgg        191
Glu Tyr Arg Ala Val Thr Glu Leu Gly Arg Pro Asp Ala Glu Tyr Trp           
        50                  55                  60                        

aat agc cag ccg gag atc ctg gag cga acg cgg gcc gag gtg gac acg        239
Asn Ser Gln Pro Glu Ile Leu Glu Arg Thr Arg Ala Glu Val Asp Thr           
    65                  70                  75                            

gtg tgc aga cac aac tac gag ggg gtg gag acc cac acc tcc ctg cgg        287
Val Cys Arg His Asn Tyr Glu Gly Val Glu Thr His Thr Ser Leu Arg           
80                  85                  90                  95            

cgg ctt gga ggt caa gac gac att gag gcc gac cac gta ggc gtc tat        335
Arg Leu Gly Gly Gln Asp Asp Ile Glu Ala Asp His Val Gly Val Tyr           
                100                 105                 110               

ggt ata gtt gta tat cag tct cct gga gac att ggc cag tac aca cat        383
Gly Ile Val Val Tyr Gln Ser Pro Gly Asp Ile Gly Gln Tyr Thr His           
            115                 120                 125                   

gaa ttt gat ggt gat gag tgg ttc tat gtg gac ttg gat aag aag gag        431
Glu Phe Asp Gly Asp Glu Trp Phe Tyr Val Asp Leu Asp Lys Lys Glu           
        130                 135                 140                       

act gtc tgg atg ctt cct gag ttt ggc caa ttg aca agc ttt gac ccc        479
Thr Val Trp Met Leu Pro Glu Phe Gly Gln Leu Thr Ser Phe Asp Pro           
    145                 150                 155                           

caa ggt gga ctg caa aac ata gct aca gga aaa cac aac ttg gga ggc        527
Gln Gly Gly Leu Gln Asn Ile Ala Thr Gly Lys His Asn Leu Gly Gly           
160                 165                 170                 175           

tgg act aag agg tca aat ttc acc cca gct acc aat taa ctcgag             572
Trp Thr Lys Arg Ser Asn Phe Thr Pro Ala Thr Asn                           
                180                 185                                   


<210>  8
<211>  187
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  8

Met Gly Gly Asn Ser Glu Arg His Phe Val Ala Gln Leu Lys Gly Glu 
1               5                   10                  15      


Cys Tyr Phe Thr Asn Gly Thr Gln Arg Ile Arg Ser Val Asn Arg Tyr 
            20                  25                  30          


Ile Tyr Asn Arg Glu Glu Trp Val Arg Phe Asp Ser Asp Val Gly Glu 
        35                  40                  45              


Tyr Arg Ala Val Thr Glu Leu Gly Arg Pro Asp Ala Glu Tyr Trp Asn 
    50                  55                  60                  


Ser Gln Pro Glu Ile Leu Glu Arg Thr Arg Ala Glu Val Asp Thr Val 
65                  70                  75                  80  


Cys Arg His Asn Tyr Glu Gly Val Glu Thr His Thr Ser Leu Arg Arg 
                85                  90                  95      


Leu Gly Gly Gln Asp Asp Ile Glu Ala Asp His Val Gly Val Tyr Gly 
            100                 105                 110         


Ile Val Val Tyr Gln Ser Pro Gly Asp Ile Gly Gln Tyr Thr His Glu 
        115                 120                 125             


Phe Asp Gly Asp Glu Trp Phe Tyr Val Asp Leu Asp Lys Lys Glu Thr 
    130                 135                 140                 


Val Trp Met Leu Pro Glu Phe Gly Gln Leu Thr Ser Phe Asp Pro Gln 
145                 150                 155                 160 


Gly Gly Leu Gln Asn Ile Ala Thr Gly Lys His Asn Leu Gly Gly Trp 
                165                 170                 175     


Thr Lys Arg Ser Asn Phe Thr Pro Ala Thr Asn 
            180                 185         


<210>  9
<211>  95
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  RTL2001 - peptide/linker encoding native bovine type II collagen 
       257-270 peptide


<220>
<221>  CDS
<222>  (3)..(95)

<400>  9
cc atg ggc gga gaa cct ggt att gct ggc ttc aaa ggt gaa caa ggc          47
   Met Gly Gly Glu Pro Gly Ile Ala Gly Phe Lys Gly Glu Gln Gly            
   1               5                   10                  15             

ccc aag ggt tct ggt tct ggt tct ggt tct ggt tct ggt tct ggt tct         95
Pro Lys Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser           
                20                  25                  30                


<210>  10
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  10

Met Gly Gly Glu Pro Gly Ile Ala Gly Phe Lys Gly Glu Gln Gly Pro 
1               5                   10                  15      


Lys Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser 
            20                  25                  30      


<210>  11
<211>  95
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  RTL2001MII - peptide/linker encoding modified bovine type II 
       collagen 257-270 peptide


<220>
<221>  CDS
<222>  (3)..(95)

<400>  11
cc atg ggc gga gaa cct ggt att gct ggc ttc aaa ggt gaa caa ggc          47
   Met Gly Gly Glu Pro Gly Ile Ala Gly Phe Lys Gly Glu Gln Gly            
   1               5                   10                  15             

ccc aag ggt tct ggt tct ggt tct ggt tct ggt tct ggt tct ggt tct         95
Pro Lys Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser           
                20                  25                  30                


<210>  12
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  12

Met Gly Gly Glu Pro Gly Ile Ala Gly Phe Lys Gly Glu Gln Gly Pro 
1               5                   10                  15      


Lys Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser 
            20                  25                  30      


<210>  13
<211>  297
<212>  PRT
<213>  Homo sapiens

<400>  13

Met Thr Thr Pro Arg Asn Ser Val Asn Gly Thr Phe Pro Ala Glu Pro 
1               5                   10                  15      


Met Lys Gly Pro Ile Ala Met Gln Ser Gly Pro Lys Pro Leu Phe Arg 
            20                  25                  30          


Arg Met Ser Ser Leu Val Gly Pro Thr Gln Ser Phe Phe Met Arg Glu 
        35                  40                  45              


Ser Lys Thr Leu Gly Ala Val Gln Ile Met Asn Gly Leu Phe His Ile 
    50                  55                  60                  


Ala Leu Gly Gly Leu Leu Met Ile Pro Ala Gly Ile Tyr Ala Pro Ile 
65                  70                  75                  80  


Cys Val Thr Val Trp Tyr Pro Leu Trp Gly Gly Ile Met Tyr Ile Ile 
                85                  90                  95      


Ser Gly Ser Leu Leu Ala Ala Thr Glu Lys Asn Ser Arg Lys Cys Leu 
            100                 105                 110         


Val Lys Gly Lys Met Ile Met Asn Ser Leu Ser Leu Phe Ala Ala Ile 
        115                 120                 125             


Ser Gly Met Ile Leu Ser Ile Met Asp Ile Leu Asn Ile Lys Ile Ser 
    130                 135                 140                 


His Phe Leu Lys Met Glu Ser Leu Asn Phe Ile Arg Ala His Thr Pro 
145                 150                 155                 160 


Tyr Ile Asn Ile Tyr Asn Cys Glu Pro Ala Asn Pro Ser Glu Lys Asn 
                165                 170                 175     


Ser Pro Ser Thr Gln Tyr Cys Tyr Ser Ile Gln Ser Leu Phe Leu Gly 
            180                 185                 190         


Ile Leu Ser Val Met Leu Ile Phe Ala Phe Phe Gln Glu Leu Val Ile 
        195                 200                 205             


Ala Gly Ile Val Glu Asn Glu Trp Lys Arg Thr Cys Ser Arg Pro Lys 
    210                 215                 220                 


Ser Asn Ile Val Leu Leu Ser Ala Glu Glu Lys Lys Glu Gln Thr Ile 
225                 230                 235                 240 


Glu Ile Lys Glu Glu Val Val Gly Leu Thr Glu Thr Ser Ser Gln Pro 
                245                 250                 255     


Lys Asn Glu Glu Asp Ile Glu Ile Ile Pro Ile Gln Glu Glu Glu Glu 
            260                 265                 270         


Glu Glu Thr Glu Thr Asn Phe Pro Glu Pro Pro Gln Asp Gln Glu Ser 
        275                 280                 285             


Ser Pro Ile Glu Asn Asp Ser Ser Pro 
    290                 295         


<210>  14
<211>  180
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Human MHC class II beta1/alpha1 molecule

<400>  14

Met Gly Asp Thr Arg Pro Arg Phe Leu Trp Gln Pro Lys Arg Glu Cys 
1               5                   10                  15      


His Phe Phe Asn Gly Thr Glu Arg Val Arg Phe Leu Asp Arg Tyr Phe 
            20                  25                  30          


Tyr Asn Gln Glu Glu Ser Val Arg Phe Asp Ser Asp Val Gly Glu Phe 
        35                  40                  45              


Arg Ala Val Thr Glu Leu Gly Arg Pro Asp Ala Glu Tyr Trp Asn Ser 
    50                  55                  60                  


Gln Lys Asp Ile Leu Glu Gln Ala Arg Ala Ala Val Asp Thr Tyr Cys 
65                  70                  75                  80  


Arg His Asn Tyr Gly Val Val Glu Ser Phe Thr Val Gln Arg Arg Val 
                85                  90                  95      


Ile Lys Glu Glu His Val Ile Ile Gln Ala Glu Phe Tyr Leu Asn Pro 
            100                 105                 110         


Asp Gln Ser Gly Glu Phe Met Phe Asp Phe Asp Gly Asp Glu Ile Phe 
        115                 120                 125             


His Val Asp Met Ala Lys Lys Glu Thr Val Trp Arg Leu Glu Glu Phe 
    130                 135                 140                 


Gly Arg Phe Ala Ser Phe Glu Ala Gln Gly Ala Leu Ala Asn Ile Ala 
145                 150                 155                 160 


Val Asp Lys Ala Asn Leu Glu Ile Met Thr Lys Arg Ser Asn Tyr Thr 
                165                 170                 175     


Pro Ile Thr Asn 
            180 


<210>  15
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MOG 35-55 peptide

<400>  15

Met Glu Val Gly Trp Tyr Arg Pro Pro Phe Ser Arg Val Val His Leu 
1               5                   10                  15      


Tyr Arg Asn Gly Lys 
            20      


<210>  16
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MOG 1-25 peptide

<400>  16

Gly Gln Phe Arg Val Ile Gly Pro Arg His Pro Ile Arg Ala Leu Val 
1               5                   10                  15      


Gly Asp Glu Val Glu Leu Pro Cys Arg 
            20                  25  


<210>  17
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MOG 95-116 peptide

<400>  17

Gly Gly Phe Thr Cys Phe Phe Arg Asp His Ser Tyr Gln Glu Glu Ala 
1               5                   10                  15      


Ala Met Glu Leu Lys Val Glu 
            20              


<210>  18
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MOG 145-160 peptide

<400>  18

Val Phe Leu Cys Leu Gln Tyr Arg Leu Arg Gly Lys Leu Arg Ala Glu 
1               5                   10                  15      


<210>  19
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MOG 194-208 peptide

<400>  19

Leu Val Ala Leu Ile Ile Cys Tyr Asn Trp Leu His Arg Arg Leu 
1               5                   10                  15  


<210>  20
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MBP 10-30 peptide

<400>  20

Arg His Gly Ser Lys Tyr Leu Ala Thr Ala Ser Thr Met Asp His Ala 
1               5                   10                  15      


Arg His Gly Phe Leu 
            20      


<210>  21
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MBP 35-45 peptide

<400>  21

Asp Thr Gly Ile Leu Asp Ser Ile Gly Arg Phe 
1               5                   10      


<210>  22
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MBP 77-91 peptide

<400>  22

Ser His Gly Arg Thr Gln Asp Glu Asn Pro Val Val His Phe 
1               5                   10                  


<210>  23
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MBP 85-99 peptide

<400>  23

Glu Asn Pro Val Val His Phe Phe Lys Asn Ile Val Thr Pro Arg 
1               5                   10                  15  


<210>  24
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MBP 95-112 peptide

<400>  24

Ile Val Thr Pro Arg Thr Pro Pro Pro Ser Gln Gly Lys Gly Arg Gly 
1               5                   10                  15      


Leu Ser 
        


<210>  25
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MBP 145-164 peptide

<400>  25

Val Asp Ala Gln Gly Thr Leu Ser Lys Ile Phe Lys Leu Gly Gly Arg 
1               5                   10                  15      


Asp Ser Arg Ser 
            20  


<210>  26
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PLP 139-151 peptide

<400>  26

Cys His Cys Leu Gly Lys Trp Leu Gly His Pro Asp Lys Phe Val Gly 
1               5                   10                  15      


<210>  27
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PLP 95-116 peptide

<400>  27

Gly Ala Val Arg Gln Ile Phe Gly Asp Tyr Lys Thr Thr Ile Cys Gly 
1               5                   10                  15      


Lys Gly Leu Ser Ala Thr 
            20          


<210>  28
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  collagen II 261-274 peptide

<400>  28

Ala Gly Phe Lys Gly Glu Gln Gly Pro Lys Gly Glu Pro Gly 
1               5                   10                  


<210>  29
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Collagen II 259-273 peptide

<400>  29

Gly Ile Ala Gly Phe Lys Gly Glu Gln Gly Pro Lys Gly Glu Pro 
1               5                   10                  15  


<210>  30
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Collagen II 257-270 peptide

<400>  30

Glu Pro Gly Ile Ala Gly Phe Lys Gly Glu Gln Gly Pro Lys 
1               5                   10                  


<210>  31
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Modified collagen II 257-270 peptide

<400>  31

Ala Pro Gly Ile Ala Gly Phe Lys Ala Glu Gln Ala Ala Lys 
1               5                   10                  


<210>  32
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Fibrinogen-alpha 40-59 peptide

<400>  32

Val Glu Arg His Gln Ser Ala Cys Lys Asp Ser Asp Trp Pro Phe Cys 
1               5                   10                  15      


Ser Asp Glu Asp 
            20  


<210>  33
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Fibrinogen-alpha 616-625 peptide

<400>  33

Thr His Ser Thr Lys Arg Gly His Ala Lys Ser Arg Pro Val Arg Gly 
1               5                   10                  15      


Ile His Thr Ser 
            20  


<210>  34
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Fibrinogen-alpha 79-91 peptide

<400>  34

Gln Asp Phe Thr Asn Arg Ile Asn Lys Leu Lys Asn Ser 
1               5                   10              


<210>  35
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Fibrinogen-alpha 121-140 peptide

<400>  35

Asn Asn Arg Asp Asn Thr Tyr Asn Arg Val Ser Glu Asp Leu Arg Ser 
1               5                   10                  15      


Arg Ile Glu Val 
            20  


<210>  36
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Vimentin 59-79 peptide

<400>  36

Gly Val Tyr Ala Thr Arg Ser Ser Ala Val Arg Leu Arg Ser Ser Val 
1               5                   10                  15      


Pro Gly Val Arg Leu 
            20      


<210>  37
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Vimentin 26-44 peptide

<400>  37

Ser Ser Arg Ser Tyr Val Thr Thr Ser Thr Arg Thr Tyr Ser Leu Gly 
1               5                   10                  15      


Ser Ala Leu 
            


<210>  38
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Vimentin 256-275 peptide

<400>  38

Ile Asp Val Asp Val Ser Lys Pro Asp Leu Thr Ala Ala Leu Arg Asp 
1               5                   10                  15      


Val Arg Gln Gln 
            20  


<210>  39
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Vimentin 415-433 peptide

<400>  39

Leu Pro Asn Phe Ser Ser Leu Asn Leu Arg Glu Thr Asn Leu Asp Ser 
1               5                   10                  15      


Leu Pro Leu 
            


<210>  40
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Alpha-enolase 5-21 peptide

<400>  40

Lys Ile His Ala Arg Glu Ile Phe Asp Ser Arg Gly Asn Pro Thr Val 
1               5                   10                  15      


Glu 
    


<210>  41
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Human cartilage glycoprotein-39 259-271 peptide

<400>  41

Pro Thr Phe Gly Arg Ser Phe Thr Leu Ala Ser Ser Glu 
1               5                   10              


<210>  42
<211>  185
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Mouse MHC class II beta1/alpha1 molecule

<400>  42

Met Gly Gly Asp Ser Glu Arg His Phe Val His Gln Phe Lys Gly Glu 
1               5                   10                  15      


Cys Tyr Phe Thr Asn Gly Thr Gln Arg Ile Arg Leu Val Thr Arg Tyr 
            20                  25                  30          


Ile Tyr Asn Arg Glu Glu Tyr Leu Arg Phe Asp Ser Asp Val Gly Glu 
        35                  40                  45              


Tyr Arg Ala Val Thr Glu Leu Gly Arg His Ser Ala Glu Tyr Tyr Asn 
    50                  55                  60                  


Lys Gln Tyr Leu Glu Arg Thr Arg Ala Glu Leu Asp Thr Ala Cys Arg 
65                  70                  75                  80  


His Asn Tyr Glu Glu Thr Glu Val Pro Thr Ser Leu Arg Arg Leu Gly 
                85                  90                  95      


Gly Glu Asp Asp Ile Glu Ala Asp His Val Gly Phe Tyr Gly Thr Thr 
            100                 105                 110         


Val Tyr Gln Ser Pro Gly Asp Ile Gly Gln Tyr Thr His Glu Phe Asp 
        115                 120                 125             


Gly Asp Glu Leu Phe Tyr Val Asp Leu Asp Lys Lys Lys Thr Val Trp 
    130                 135                 140                 


Arg Leu Pro Glu Phe Gly Gln Leu Ile Leu Phe Glu Pro Gln Gly Gly 
145                 150                 155                 160 


Leu Gln Asn Ile Ala Ala Glu Lys His Asn Leu Gly Ile Leu Thr Lys 
                165                 170                 175     


Arg Ser Asn Phe Thr Pro Ala Thr Asn 
            180                 185 


<210>  43
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Linker peptide

<400>  43

Gly Gly Gln Asp Asp 
1               5   


<210>  44
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Linker peptide

<400>  44

Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser 
1               5                   10                  


<210>  45
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Linker peptide

<400>  45

Gly Ser Gly Ser Gly Ser Gly Ser 
1               5               


